
Ovom Care GmbH is a tech-enabled fertility and reproductive care company that redefines fertility treatment by combining advanced AI technology, precision medicine, and compassionate patient-centered care. They offer a comprehensive digital ecosystem supporting assisted reproductive medicine with services including IVF, egg freezing, fertility testing, donor programs, and fertility coaching. Their clinics in Portugal, London, Germany, and the US provide state-of-the-art labs and industry-leading experts, delivering personalized treatment pathways with radical transparency and 24/7 support. Ovom Care aims to make fertility care more accessible, affordable, and successful, with success-based pricing and flexible financing options, serving a global patient base including LGBTQIA+ families and international patients.

Ovom Care GmbH is a tech-enabled fertility and reproductive care company that redefines fertility treatment by combining advanced AI technology, precision medicine, and compassionate patient-centered care. They offer a comprehensive digital ecosystem supporting assisted reproductive medicine with services including IVF, egg freezing, fertility testing, donor programs, and fertility coaching. Their clinics in Portugal, London, Germany, and the US provide state-of-the-art labs and industry-leading experts, delivering personalized treatment pathways with radical transparency and 24/7 support. Ovom Care aims to make fertility care more accessible, affordable, and successful, with success-based pricing and flexible financing options, serving a global patient base including LGBTQIA+ families and international patients.
Sector: AI-driven fertility and reproductive healthcare
Headquarters: Berlin, Germany
Stage / Funding: Seed (announced 2024-04-30)
Employees (reported): 11–50 (reported)
Fertility and assisted reproductive medicine; improving treatment personalization and outcomes using AI-driven predictive analytics.
Healthcare / Fertilitytech
€4.8M
Participating investors reported to include Merantix Capital and Ananda Impact Ventures; reported amount in press coverage associated with the round €4.8M.
“Lead investor: Alpha Intelligence Capital; participation by Merantix Capital and Ananda Impact Ventures”